Регистрация
Забыли свой пароль?
  1. Главная
  2. Каталог статей
  3. Креативная кардиология. 2017; 11(4)
  4. Заболевания перикарда: этиология, патофизиология, диагностика и лечение

Заболевания перикарда: этиология, патофизиология, диагностика и лечение

Авторы: О.В. Касьянова

Организация:
Кафедра кардиологии ФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Минздрава России; ул. Делегатская, 20/1, Москва, 127473, Российская Федерация

Для корреспонденции: Сведения доступны для зарегистрированных пользователей.

Тип статьи: Некоронарогенные заболевания сердца

DOI: https://doi.org/10.24022/1997-3187-2017-11-4-326-336

УДК: 616.11-02-092-07-08

Для цитирования:  Касьянова О.В. Заболевания перикарда: этиология, патофизиология, диагностика и лечение. Креативная кардиология. 2017; 11 (4): 326–36. DOI: 10.24022/1997-3187-2017-11-4-326-336

Поступила / Принята к печати:  30.05.2017/30.10.2017

Ключевые слова: заболевания перикарда, этиология, диагностика, лечение, прогноз

Скачать (Download)


 

Аннотация

Заболевания перикарда – достаточно распространенная патология, с которой приходится сталкиваться врачам различных специальностей, нередко представляющая трудности в диагностике. В статье обсуждаются наиболее важные вопросы и новые данные на основе материалов Европейского общества кардиологов по диагностике и ведению пациентов с заболеваниями перикарда, опубликованных в 2015 г.

Литература

  1. Maisch B., Seferović P.M., Ristić A.D., Erbel R., Rienmüller R., Adler Y. et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur. Heart J. 2004; 25: 587–610.

  2. Adler Y., Charron Y., Imazio M., Badano L., Baron-Esquivias G., Bogaert J. et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2015; 36 (42): 2921–64.

  3. Guindo J. Comments on the 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. A Report by the Spanish Society of Cardiology Guidelines Committee Working Group. Rev. Esp. Cardiol. 2015; 68: 1068–74.

  4. Kyto V., Sipila J., Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014; 130: 1601–6.

  5. Imazio M., Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015; 101: 1159–68.

  6. Frisancho-Kiss S., Coronado M.J., Frisancho J.A., Lau V.M., Rose N.R., Klein S.L., Fairweather D. Gonadectomy of male BALB/c mice increases Tim-3 (+) alternatively activated M2 macrophages, Tim-3 (+) T cells, Th2 cells and Treg in the heart during acute coxsackie virus induced myocarditis. Brain. Behav. Immun. 2009; 23: 649–57.

  7. Lyden D.C., Olszewski J., Feran M., Job L.P., Huber S.A. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 1987; 126: 432–8.

  8. Li Z., Yue Y., Xiong S. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis. Cardiovasc. Pathol. 2013; 22: 373–82.

  9. Huber S.A. Coxsackievirus B3-induced myocarditis: Infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells. Virology. 2008; 378 (2): 292–8.

  10. Imazio M., Cecchi E., Demichelis B., Chinaglia A., Ierna S., Demarie D. et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008; 94: 498–501.

  11. Imazio M., Bobbio M., Cecchi E., Demarie D., Demichelis B., Pomari F. et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005; 112: 2012–6.

  12. Imazio M., Brucato A., Cemin R., Ferrua S., Maggiolini S., Beqaraj F. et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N. Engl. J. Med. 2013; 369: 1522–8.

  13. Admetlla M., Cequier A., Amer R., Javaloyas M., Sabate X., Gausi C. Acute idiopathic pericarditis: clinical features, development and complications: prospective study of 101 cases. Med. Clin. (Barc.). 1985; 85: 563–7.

  14. Imazio M., Spodick D.H., Brucato A., Trinchero R., Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010; 121: 916–28.

  15. Cosyns B., Plein S., Nihoyanopoulos P., Smiseth O., Achenbach S., Andrade M.J. et al. On behalf of the European Association of Cardiovascular Imaging (EACVI) and European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur. Heart J. Cardiovasc. Imaging. 2014; 16: 12–31.

  16. Lobert P., Brown R.K., Dvorak R.A., Corbett J.R., Kazerooni E.A., Wong K.K. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clin. Radiol. 2013; 68: e59–71.

  17. Imazio M., Cecchi E., Demichelis B., Ierna S., Demarie D., Ghisio A. et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007; 115: 2739–44.

  18. Alabed S., Cabello J.B., Irving G.J., Qintar M., Burls A. Colchicine for pericarditis. Cochrane Database Syst. Rev. 2014; 8: CD010652.

  19. Pelliccia A., Corrado D., Bjo⁄ rnstad H.H., Panhuyzen-Goedkoop N., Urhausen A., Carre F. et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur. J. Cardiovasc. Prev. Rehabil. 2006; 13: 876–85.

  20. Imazio M., Brucato A., Cumetti D., Brambilla G., Demichelis B., Ferro S. et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008; 118: 667–71.

  21. Imazio M., Adler Y. Management of pericardial effusion. Eur. Heart J. 2013; 34: 1186–97.

  22. Imazio M., Brucato A., Maestroni S., Cumetti D., Dominelli A., Natale G., Trinchero R. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011; 123: 1092–7.

  23. Alraies M.C., AlJaroudi W., Yarmohammadi H., Yingchoncharoen T., Schuster A., Senapati A. et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am. J. Cardiol. 2015; 115: 542–7.

  24. Imazio M., Belli R., Brucato A., Cemin R., Ferrua S., Beqaraj F. et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, doubleblind, placebo-controlled, randomized trial. Lancet. 2014; 383: 2232–7.

  25. Imazio M., Bobbio M., Cecchi E., Demarie D., Pomari F., Moratti M. et al. Colchicine as firstchoice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch. Intern. Med. 2005; 165: 1987–91.

  26. Lotrionte M., Biondi-Zoccai G., Imazio M., Castagno D., Moretti C., Abbate A. et al.International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am. Heart J. 2010; 160: 662–70.

  27. Brucato A., Brambilla G., Moreo A., Alberti A., Munforti C., Ghirardello A. et al. Longterm outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 2006; 98: 267–71.

  28. Khandaker M.H., Schaff H.V., Greason K.L., Anavekar N.S., Espinosa R.E., Hayes S.N. et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin. Proc. 2012; 87: 1062–70.

  29. Imazio M., Brucato A., Barbieri A., Ferroni F., Maestroni S., Ligabue G. et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013; 128: 42–9.

  30. Imazio M., Brucato A., Spodick D.H., Adler Y. Prognosis of myopericarditis as determined from previously published reports. J. Cardiovasc. Med. (Hagerstown). 2014; 15: 835–9.

  31. Imazio M., Brucato A., Barbieri A., Ferroni F., Maestroni S., Ligabue G. et al. Good prognosis for pericarditis withand without myocardial involvement: results from a multicenter, prospective cohortstudy. Circulation. 2013; 128: 42–9.

  32. Imazio M., Brucato A., Belli R., Forno D., Ferro S., Trinchero R., Adler Y. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 – systematic review and meta-analysis. J. Cardiovasc. Med. (Hagerstown). 2014; 15: 840–6.

  33. Mitiku T.Y., Heidenreich P.A. A small pericardial effusion is a marker of increased mortality. Am. Heart J. 2011; 161: 152–7.

  34. Ristić A.D., Imazio M., Adler Y., Anastasakis A., Badano L.P., Brucato A. et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2014; 35: 2279–84.

  35. Imazio M., Brucato A., Adler Y., Brambilla G., Artom G., Cecchi E. et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am. J. Cardiol. 2007; 100: 1026–8.

  36. Mayosi B.M., Burgess L.J., Doubell A.F. Tuberculous pericarditis. Circulation. 2005; 112: 3608–16.

  37. Imazio M., Brucato A., Mayosi B.M., Derosa F.G., Lestuzzi C., Macor A. et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J. Cardiovasc. Med. (Hagerstown). 2010; 11: 785–94.

  38. DeValeria P.A., Baumgartner W.A., Casale A.S., Greene P.S., Cameron D.E., Gardner T.J. Current indications, risks, and outcome after pericardiectomy. Ann. Thorac. Surg. 1991; 52: 219–24.

  39. Mayosi B.M., Ntsekhe M., Volmink J.A., Commerford P.J. Interventions for treating tuberculous pericarditis. Cochrane Database Syst. Rev. 2002; 4: CD000526.

  40. Geggel R.L. Conditions leading to pediatric cardiology consultation in a tertiary academic hospital pediatrics. Pediatrics. 2004; 114: 409–17.

  41. Shakti D., Hehn R., Gauvreau K., Sundel R.P., Newburger J.W. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J. Am. Heart Assoc. 2014; 3: e001483.

  42. Imazio M., Brucato A., Pluymaekers N., Breda L., Calabri G., Cantarini L. et al. Recurrent pericarditis in children and adolescents: etiology, presentation, therapies, and outcomes. A multicenter cohort study. J. Cardiovasc. Med. 2016; 17 (9): 707–12.

  43. Picco P., Brisca G., Traverso F., Loy A., Gattorno M., Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009; 60: 264–8.

  44. Ristić A.D., Seferović P.M., Ljubić A., Jovanović I., Ristić G., Pankuweit S. et al. Pericardial disease in pregnancy. Herz. 2003; 28: 209–15.

  45. Brucato A., Imazio M., Curri S., Palmieri G., Trinchero R. Medical treatment of pericarditis during pregnancy. Int. J. Cardiol. 2010; 144: 413–4.

  46. Pasina L., Brucato A.L., Falcone C., Cucchi E., Bresciani A., Sottocorno M. et al. Medicationn on-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014; 31: 283–9.

Об авторах

Касьянова Ольга Владимировна, канд. мед. наук, ассистент кафедры, orcid.org/0000-0002-0620-2119

Электронная подписка

Для получения доступа к тексту статей журнала воспользуйтесь услугой «Электронная подписка»:

Оформить подписку Подробнее об электронной подписке

Главный редактор

Лео Антонович Бокерия, академик РАН и РАМН

Лео Антонович Бокерия, доктор медицинских наук, профессор, академик РАН и РАМН, президент


Сортировать по


 Если вы заметили опечатку, выделите текст и нажмите alt+A